Design Therapeutics, Inc. (DSGN) SEC Filings — 2025
8 SEC filings for Design Therapeutics, Inc. (DSGN) in 2025.
Filings
- Design Therapeutics' Losses Widen Amid R&D Surge — 10-Q · Nov 5, 2025
- Design Therapeutics Reports Officer and Director Changes — 8-K · Sep 10, 2025
- Design Therapeutics' Q2 Net Loss Widens to $26.8M Amid R&D Spend — 10-Q · Aug 7, 2025
- Design Therapeutics Reports on Shareholder Vote Matters — 8-K · Jun 12, 2025
- Design Therapeutics Q1 2025 Update — 10-Q · May 7, 2025
- Design Therapeutics Proxy Statement Filed — DEF 14A · Apr 24, 2025
- Design Therapeutics, Inc. 10-K Filing — 10-K · Mar 10, 2025
- Design Therapeutics Files 8-K — 8-K · Jan 13, 2025